SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-010552
Filing Date
2023-05-26
Accepted
2023-05-26 16:36:33
Documents
17
Period of Report
2023-05-24
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20230524x8k.htm   iXBRL 8-K 55723
2 EX-3.1 ampe-20230524xex3d1.htm EX-3.1 5428
3 EX-3.2 ampe-20230524xex3d2.htm EX-3.2 34245
4 EX-99.1 ampe-20230524xex99d1.htm EX-99.1 11318
5 GRAPHIC ampe-20230524x8k006.jpg GRAPHIC 2763
6 GRAPHIC ampe-20230524xex99d1001.jpg GRAPHIC 10740
  Complete submission text file 0001558370-23-010552.txt   267047

Data Files

Seq Description Document Type Size
7 EX-101.SCH ampe-20230524.xsd EX-101.SCH 3369
8 EX-101.LAB ampe-20230524_lab.xml EX-101.LAB 16014
9 EX-101.PRE ampe-20230524_pre.xml EX-101.PRE 10865
11 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20230524x8k_htm.xml XML 4864
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 23969648
SIC: 2834 Pharmaceutical Preparations